Back
Dyne Therapeutics Stock Price Chart

The Tariff-Proof Asset in Your Pocket
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
17
DYN
Dyne Therapeutics
Last Price:
$9.43
Seasonality Move:
15.1%
7 Day Trial
ALL ACCESS PASS
$
7

Apple's Drop in iPhone Sales Opens the Door for New Entrant
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
The current trend is moderately bullish and DYN is experiencing slight buying pressure.
Dyne Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 10.99 | Sell |
20-day SMA: | 11.73 | Sell |
50-day SMA: | 13.08 | Sell |
200-day SMA: | 28.47 | Sell |
8-day EMA: | 9.75 | Buy |
20-day EMA: | 6.94 | Buy |
50-day EMA: | 3.67 | Buy |
200-day EMA: | 1.07 | Buy |
Dyne Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.85 | Buy |
Relative Strength Index (14 RSI): | 33.59 | Sell |
Chaikin Money Flow: | 1319273 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
Dyne Therapeutics Technical Analysis
Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | Mar 31 | Apr 1 | Apr 2 | Apr 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | Apr | |||||||||
21 | 24 | 25 | 26 | 27 | 28 | 31 | 01 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Dyne Therapeutics Stock
Is Dyne Therapeutics Stock a Buy?
-
Dyne Therapeutics share price is 9.91 while DYN 8-day simple moving average is 10.99, which is a Sell signal.
-
The stock price of DYN is 9.91 while Dyne Therapeutics 20-day SMA is 11.73, which makes it a Sell.
-
Dyne Therapeutics 50-day simple moving average is 13.08 while DYN share price is 9.91, making it a Sell technically.
-
DYN stock price is 9.91 and Dyne Therapeutics 200-day simple moving average is 28.47, creating a Sell signal.
DYN Technical Analysis vs Fundamental Analysis
Sell
17
Dyne Therapeutics (DYN)
is a Sell
Is Dyne Therapeutics a Buy or a Sell?
-
Dyne Therapeutics stock is rated a SellThe current Dyne Therapeutics [DYN] share price is $9.91. The Score for DYN is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.
Dyne Therapeutics Stock Info
Market Cap:
1.1B
Price in USD:
9.91
Share Volume:
2.7M
Dyne Therapeutics 52-Week Range
52-Week High:
47.45
52-Week Low:
8.94
Sell
17
Dyne Therapeutics (DYN)
is a Sell
Dyne Therapeutics Share Price Forecast
-
What is the Dyne Therapeutics stock price today?The Dyne Therapeutics stock price is 9.91 USD today.
-
Will DYN stock go up or go down?Dyne Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Dyne Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Dyne Therapeutics is overvalued.
Is Dyne Therapeutics Stock a Buy?
-
Dyne Therapeutics share price is 9.91 while DYN 8-day exponential moving average is 9.75, which is a Buy signal.
-
The stock price of DYN is 9.91 while Dyne Therapeutics 20-day EMA is 6.94, which makes it a Buy.
-
Dyne Therapeutics 50-day exponential moving average is 3.67 while DYN share price is 9.91, making it a Buy technically.
-
DYN stock price is 9.91 and Dyne Therapeutics 200-day simple moving average is 1.07, creating a Buy signal.
Fundamental Analysis of Dyne Therapeutics
Is Dyne Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.17 per share, a decrease next quarter of $0.07 per share, a decrease this year of $0.03 per share, and a decrease next year of $0.14 per share.
Technical Analysis of Dyne Therapeutics
Should I short Dyne Therapeutics stock?
-
DYN Moving Average Covergence Divergence (MACD) indicator is 2.85, suggesting Dyne Therapeutics is a Buy
-
Dyne Therapeutics Relative Strength Index (RSI) is 33.59, which suggest Dyne Therapeutics is oversold
-
The Bollinger Bands (25) for Dyne Therapeutics is ( - ), which suggest Dyne Therapeutics is a Buy
-
The Bollinger Bands (100) for Dyne Therapeutics is ( - ), which suggest Dyne Therapeutics is a Buy
* Dyne Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.